57775-29-8
57775-29-8
Chemical Structure
Carazolol
Synonym(s): (±)-Carazolol; DL-Carazolol; Suacron
- CAS No.: 57775-29-8
- Formula:C18H22N2O2
- Molecular Weight:298.38
IUPAC Name: 1-((9H-carbazol-4-yl)oxy)-3-(isopropylamino)propan-2-ol
InChIKey: BQXQGZPYHWWCEB-UHFFFAOYSA-N
SMILES: CC(C)NCC(O)COC1=CC=CC2=C1C3=CC=CC=C3N2
Biological Activity: Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Carazolol | 99.78% | Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carazolol (Standard) | ≥98% | Carazolol (Standard) is the analytical standard of Carazolol. This product is intended for research and analytical applications. Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carazolol-d7 hydrochloride | Carazolol-d7 (hydrochloride) is the deuterium labeled Carazolol hydrochloride (HY-W517264). Carazolol hydrochloride is a highly potent antagonist of β1/β2 adrenoceptor. Carazolol hydrochloride is also a potent, selective β3-adrenoceptor agonist. Carazolol hydrochloride can be used in the research of hypertension. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carazolol-d7 | 99.0% | Carazolol-d7 is the deuterium labeled Carazolol (HY-107327). Carazolol is a highly potent antagonist of β1/β2 adrenoceptor. Carazolol is also a potent, selective β3-adrenoceptor agonist. Carazolol can be used in the research of hypertension. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
